Discoveries beyond molecular mimicry describe how EBV drives multiple sclerosis
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- Anoctamin-2-specific T cells link Epstein-Barr virus to multiple sclerosisCell, 2026
- EBV infection and HLA-DR15 jointly drive multiple sclerosis by myelin peptide presentationCell, 2026
- Myelin antigen capture in the CNS by B cells expressing EBV latent membrane protein 1 leads to demyelinating lesion formationCell, 2026
- Antibody reactivity against EBNA1 and GlialCAM differentiates multiple sclerosis patients from healthy controlsProceedings of the National Academy of Sciences, 2025
- Epstein–Barr virus and the immune microenvironment in multiple sclerosis: Insights from high-dimensional brain tissue imagingProceedings of the National Academy of Sciences, 2025
- Clonally expanded B cells in multiple sclerosis bind EBV EBNA1 and GlialCAMNature, 2022
- Longitudinal analysis reveals high prevalence of Epstein-Barr virus associated with multiple sclerosisScience, 2022
- Epstein Barr virus nuclear antigen 1 (EBNA-1) peptides recognized by adult multiple sclerosis patient sera induce neurologic symptoms in a murine modelJournal of Autoimmunity, 2020
- Protective and therapeutic role for αB-crystallin in autoimmune demyelinationNature, 2007
- Prevention of experimental autoimmune encephalomyelitis by antibodies against α4βl integrinNature, 1992